comparemela.com

Latest Breaking News On - Aibo wei - Page 1 : comparemela.com

金凯生科:努力成为具有竞争性、成长型、全球化的CDMO企业 _ 东方财富网

中宏网股票频道9月15日电近年来,随着医药产业的蓬勃发展,药物分子结构日趋复杂、新药研发风险不断加大,制药企业的研发生产成本不断增加,寻找专业化的定制外包服务成为大部分制药企业的选择。CDMO模式下,制药企业通过负责发现对某一疾病起治疗作用的化合物,而CDMO企业则负责进行化合物的工艺开发和生产。

United-states
America
Kay-liaoning
Novartis-boehringer-ingelheim
Aibo-wei
Group-genesis
Chemical-group
Bayer-hui-switzerland
Cdmo
成为
企业
金凯生科

世界特应性皮炎日:超过3000万人被缠身,这种皮肤病让人"抓"狂_中华网

世界特应性皮炎日:超过3000万人被缠身,这种皮肤病让人"抓"狂_中华网
china.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from china.com Daily Mail and Mail on Sunday newspapers.

China
Aibo-wei
High-school
Association-china
Health-news-china-youth-daily
College-general-assembly
General-assembly
Country-region
Science-management

恒瑞"1.5折发股票"背后:国内药企如何突破业绩支撑的创新困局?_医疗_产经频道首页_财经网

恒瑞"1.5折发股票"背后:国内药企如何突破业绩支撑的创新困局?_医疗_产经频道首页_财经网
caijing.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from caijing.com.cn Daily Mail and Mail on Sunday newspapers.

China
Shanghai
Hong-kong
Switzerland
Shenzhen
Guangdong
Aibo-wei
Health-shanghai-shenzhen-pass
Bi-china-life-sciences
Life-sciences
Shanghai-stock-exchange-division
Channel-home-finance

天境生物公布其差异化的CD47抗体来佐利单抗的多项重要临床进展-美通社PR-Newswire

天境生物公布其差异化的CD47抗体来佐利单抗的多项重要临床进展-美通社PR-Newswire
prnasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnasia.com Daily Mail and Mail on Sunday newspapers.

China
California
United-states
Shanghai
Lishui-hong-kong
Aibo-wei
Research-china-shanghai
Progress-us-pass-agency
Other-service
Society-annual-meeting
China-research
Nasdaq

海和药物IPO被否启示录:创新药企"买买买"模式还被资本看好吗? _ 东方财富网

海和药物IPO被否启示录:创新药企"买买买"模式还被资本看好吗? _ 东方财富网
eastmoney.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eastmoney.com Daily Mail and Mail on Sunday newspapers.

China
Rongchang
Chongqing
Xudong
Guangdong
Thailand
Hong-kong
Jianmin
Jiangsu
Martin-sea
Aibo-wei
Innovation-association
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.